A previous study from our group, involving a smaller cohort of lung cancer patients, revealed similar biomarker expression levels, indicating that elevated expression of CXCR4 and JUNB is associated with poorer OS in extended‐stage SCLC [29]. This evidence concerns the gene JUNB and lung cancer.